Module 02 Course Project – The Myths of Lobbyists/Part Assignment

DATE: August 30, 2019

TIME: 3:00 PM

LOCATION: ACA Meeting Room

Facilitator: Sharlene Salinas, Clinic Supervisor

AGENDA DETAILS Comment by [email protected]: Be sure to add attendees/invitees

I. Lobbying in 1997 to 2000 in the pharmaceutical industry

a. The industry lobbied against price controls

b. The constant rise in prices made medicine to become too expensive

c. The bill to control the continued growth was important

II. Lobbying against the Heath Care Act reforms

a. The reforms targeted reducing the amount of money sent to Medicaid

b. The reforms increased the amount paid to insurance by the elderly.

c. Lobbying was to ensure increased funds in health care and protect the elderly.

III. Effects of pharmaceutical lobbing

a. Increased health care costs

b. The frustration of the bills on price controls

IV. Effects of lobbying against the Health Care Act

a. Increase in Medicaid

b. Increased access to health care due to the increased number of people being covered

c. The reduced financial burden on the elderly.

V. Impacts of the lobbying activities to patients

a. Lobbying against the Health Care Act had a positive effect on the patients

b. Lobbying for pharmaceutical company freedom had a negative impact on patients